Bm Pimples Cure Cream
NDC Package 85816-6024-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Bm Pimples Cure (berberis aquifolium, hydrocotyle, kali bromatum, zinc oxide) cream is indications: (Derived from Materia Medica by W. This formulation utilizes a cream delivery system. Marketed by Bm Private Limited, this product is identified by NDC 85816-6024.

Identification & Billing

NDC Package Code
85816-6024-1
Package Description
40 g in 1 JAR
Product Code
85816-6024
11-Digit Billing Format
85816602401

Clinical Specifications

Proprietary Name
Bm Pimples Cure
Non-Proprietary Name
Berberis Aquifolium, Hydrocotyle, Kali Bromatum, Zinc Oxide
Substance Name
Berberis Aquifolium Root Bark; Centella Asiatica Whole; Potassium Bromide; Zinc Oxide
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Indications: (Derived from Materia Medica by W. Boericke, 1200 Remedies by R. Murphy, Materia Media by Blackwood & authentic homoeopathic references). Help support to relieve the symptoms of acne and pimples, for detail please read the enclosed package (Product information leaflet).

Regulatory & Marketing

Labeler Name
Bm Private Limited
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
01-01-2015
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85816-6024-1 identifies a specific commercial package of 40 g in 1 jar of Bm Pimples Cure, a human over the counter drug labeled by Bm Private Limited. This cream is formulated for topical use and contains berberis aquifolium root bark; centella asiatica whole; potassium bromide; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bm Private Limited on January 01, 2015. The current certification is valid through December 31, 2027.

How is this Bm Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85816602401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
85816-6024-1
11-Digit CMS (5-4-2)
85816-6024-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.